Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:country |
gptkb:Germany
|
| gptkbp:focus |
cancer therapeutics
|
| gptkbp:foundedBy |
gptkb:Evotec_SE
|
| gptkbp:foundedIn |
2019
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:location |
gptkb:Hamburg,_Germany
|
| gptkbp:parentCompany |
gptkb:Evotec_SE
|
| gptkbp:specializesIn |
DNA damage response inhibitors
|
| gptkbp:website |
https://breakpoint-tx.com/
|
| gptkbp:bfsParent |
gptkb:Cord_Dohrmann
|
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
Breakpoint Therapeutics
|